Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Inspire Medical participates in a webcast with Wells Fargo » 10:25
04/01/21
04/01
10:25
04/01/21
10:25
INSP

Inspire Medical

$216.00 /

+9.27 (+4.48%)

Wells Fargo hosts…

Wells Fargo hosts management in its MedTech Research & Development R&D Spotlight webcast on April 1 at 11 am. Webcast Link

ShowHide Related Items >><<
INSP Inspire Medical
$216.00 /

+9.27 (+4.48%)

INSP Inspire Medical
$216.00 /

+9.27 (+4.48%)

02/24/21 Lake Street
Inspire Medical price target raised to $250 from $215 at Lake Street
02/24/21 SVB Leerink
Inspire Medical price target raised to $275 from $225 at SVB Leerink
02/24/21 Piper Sandler
Inspire Medical price target raised to $252 from $210 at Piper Sandler
01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
INSP Inspire Medical
$216.00 /

+9.27 (+4.48%)

  • 14
    Apr
INSP Inspire Medical
$216.00 /

+9.27 (+4.48%)

Conference/Events
Inspire Medical participates in a webcast with Wells Fargo » 08:28
04/01/21
04/01
08:28
04/01/21
08:28
INSP

Inspire Medical

$206.73 /

+9.74 (+4.94%)

Wells Fargo hosts…

Wells Fargo hosts management in its MedTech Research & Development R&D Spotlight webcast on April 1 at 11 am. Webcast Link

ShowHide Related Items >><<
INSP Inspire Medical
$206.73 /

+9.74 (+4.94%)

INSP Inspire Medical
$206.73 /

+9.74 (+4.94%)

02/24/21 Lake Street
Inspire Medical price target raised to $250 from $215 at Lake Street
02/24/21 SVB Leerink
Inspire Medical price target raised to $275 from $225 at SVB Leerink
02/24/21 Piper Sandler
Inspire Medical price target raised to $252 from $210 at Piper Sandler
01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
INSP Inspire Medical
$206.73 /

+9.74 (+4.94%)

  • 14
    Apr
INSP Inspire Medical
$206.73 /

+9.74 (+4.94%)

Hot Stocks
Inspire Medical receives FDA approval for physician programmer platform » 16:22
03/31/21
03/31
16:22
03/31/21
16:22
INSP

Inspire Medical

$206.73 /

+9.74 (+4.94%)

Inspire Medical announced…

Inspire Medical announced receipt of FDA approval for the new Inspire physician programmer platform. The company said the most significant enhancement associated with this approval is the new telemetry cable which enables Bluetooth connectivity to the programmer tablet.

ShowHide Related Items >><<
INSP Inspire Medical
$206.73 /

+9.74 (+4.94%)

INSP Inspire Medical
$206.73 /

+9.74 (+4.94%)

02/24/21 Lake Street
Inspire Medical price target raised to $250 from $215 at Lake Street
02/24/21 SVB Leerink
Inspire Medical price target raised to $275 from $225 at SVB Leerink
02/24/21 Piper Sandler
Inspire Medical price target raised to $252 from $210 at Piper Sandler
01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
INSP Inspire Medical
$206.73 /

+9.74 (+4.94%)

  • 14
    Apr
INSP Inspire Medical
$206.73 /

+9.74 (+4.94%)

Over a month ago
On The Fly
Fly Intel: After-Hours Movers » 19:07
03/15/21
03/15
19:07
03/15/21
19:07
ZDGE

Zedge

$11.48 /

+1.2 (+11.67%)

, AMPH

Amphastar

$19.17 /

-0.21 (-1.08%)

, INSP

Inspire Medical

$217.98 /

-0.26 (-0.12%)

, NWS

News Corp

$24.73 /

-0.19 (-0.76%)

, ACRX

AcelRx

$2.17 /

-0.04 (-1.81%)

, ASLE

AerSale

$11.15 /

+1.155 (+11.56%)

, HQY

HealthEquity

$80.26 /

+1.09 (+1.38%)

, CLSK

CleanSpark

$29.40 /

-1.5 (-4.85%)

, IMAX

Imax

$23.45 /

-0.02 (-0.09%)

, NKLA

Nikola

$17.07 /

+0.07 (+0.41%)

, RUBI

Rubicon Project

$0.00 /

+ (+0.00%)

, MAXR

Maxar Technologies

$47.79 /

+1.07 (+2.29%)

, PAYA

Paya Holdings

$13.28 /

+0.03 (+0.23%)

Check out this evening's…

ShowHide Related Items >><<
PAYA Paya Holdings
$13.28 /

+0.03 (+0.23%)

NWS News Corp
$24.73 /

-0.19 (-0.76%)

NKLA Nikola
$17.07 /

+0.07 (+0.41%)

MAXR Maxar Technologies
$47.79 /

+1.07 (+2.29%)

INSP Inspire Medical
$217.98 /

-0.26 (-0.12%)

IMAX Imax
$23.45 /

-0.02 (-0.09%)

HQY HealthEquity
$80.26 /

+1.09 (+1.38%)

CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

ASLE AerSale
$11.15 /

+1.155 (+11.56%)

AMPH Amphastar
$19.17 /

-0.21 (-1.08%)

ACRX AcelRx
$2.17 /

-0.04 (-1.81%)

ZDGE Zedge
$11.48 /

+1.2 (+11.67%)

02/11/21
Fly Intel: Top five analyst initiations
02/11/21 Maxim
Zedge initiated with a Buy at Maxim
AMPH Amphastar
$19.17 /

-0.21 (-1.08%)

01/08/21 Wells Fargo
Amphastar downgraded to Equal Weight from Overweight at Wells Fargo
10/05/20 Northland
Amphastar upgraded to Outperform from Market Perform at Northland
07/09/20 Northland
Amphastar downgraded to Market Perform from Outperform at Northland
05/01/20
Fly Intel: Top five analyst initiations
INSP Inspire Medical
$217.98 /

-0.26 (-0.12%)

02/24/21 Lake Street
Inspire Medical price target raised to $250 from $215 at Lake Street
02/24/21 SVB Leerink
Inspire Medical price target raised to $275 from $225 at SVB Leerink
02/24/21 Piper Sandler
Inspire Medical price target raised to $252 from $210 at Piper Sandler
01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
NWS News Corp
$24.73 /

-0.19 (-0.76%)

ACRX AcelRx
$2.17 /

-0.04 (-1.81%)

02/17/21 H.C. Wainwright
AcelRx warning letter is a 'nothingburger,' says H.C. Wainwright
07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
07/20/20
Fly Intel: Top five analyst downgrades
07/20/20 Credit Suisse
AcelRx downgraded to Underperform on 'mounting challenges' at Credit Suisse
ASLE AerSale
$11.15 /

+1.155 (+11.56%)

01/07/21 Cowen
AerSale initiated with a Market Perform at Cowen
HQY HealthEquity
$80.26 /

+1.09 (+1.38%)

02/10/21 Raymond James
HealthEquity price target raised to $100 from $75 at Raymond James
02/09/21 Barrington
HealthEquity price target raised to $90 from $75 at Barrington
02/09/21 Truist
HealthEquity price target raised to $92 from $80 at Truist
02/09/21 RBC Capital
HealthEquity price target raised to $87 from $74 at RBC Capital
CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

03/10/21 BTIG
CleanSpark initiated with a Buy at BTIG
03/10/21 BTIG
CleanSpark initiated with a Buy at BTIG
02/16/21 H.C. Wainwright
CleanSpark price target raised to $50 from $24 at H.C. Wainwright
12/11/20 H.C. Wainwright
CleanSpark price target raised to $24 from $18 at H.C. Wainwright
IMAX Imax
$23.45 /

-0.02 (-0.09%)

03/09/21 Barrington
Imax price target raised to $27 from $25 at Barrington
03/05/21 Macquarie
Imax price target raised to $25 after Q4 earnings beat at Macquarie
03/05/21 Benchmark
Imax price target raised to $24 from $22 at Benchmark
03/01/21 Wedbush
Imax price target raised to $22 from $14 at Wedbush
NKLA Nikola
$17.07 /

+0.07 (+0.41%)

03/05/21
Fly Intel: Top five analyst downgrades
03/05/21 JPMorgan
JPMorgan lowers Bloom Energy target but now prefers over Nikola
03/05/21 JPMorgan
Nikola downgraded to Neutral from Overweight at JPMorgan
02/01/21
Fly Intel: Top five analyst upgrades
RUBI Rubicon Project
$0.00 /

+ (+0.00%)

06/26/20 B. Riley
Rubicon Project meetings suggest Q2 outlook conservative, says B. Riley FBR
04/02/20 Craig-Hallum
Rubicon Project price target lowered to $9 from $14 at Craig-Hallum
MAXR Maxar Technologies
$47.79 /

+1.07 (+2.29%)

02/25/21 Canaccord
Maxar Technologies price target raised to $55 from $50 at Canaccord
02/19/21 Canaccord
Maxar Technologies price target raised to $50 from $40 at Canaccord
01/21/21
Fly Intel: Top five analyst downgrades
01/21/21 JPMorgan
JPMorgan downgrades Maxar, says take profits after 85% rally
PAYA Paya Holdings
$13.28 /

+0.03 (+0.23%)

03/08/21 BTIG
Paya Holdings Q4 shows bull thesis intact, says BTIG
02/26/21 Raymond James
Paya Holdings initiated with an Outperform at Raymond James
02/23/21 DA Davidson
Paya Holdings initiated with a Buy at DA Davidson
02/23/21 DA Davidson
Paya Holdings initiated with a Buy at DA Davidson
ZDGE Zedge
$11.48 /

+1.2 (+11.67%)

PAYA Paya Holdings
$13.28 /

+0.03 (+0.23%)

NWS News Corp
$24.73 /

-0.19 (-0.76%)

NKLA Nikola
$17.07 /

+0.07 (+0.41%)

MAXR Maxar Technologies
$47.79 /

+1.07 (+2.29%)

INSP Inspire Medical
$217.98 /

-0.26 (-0.12%)

IMAX Imax
$23.45 /

-0.02 (-0.09%)

HQY HealthEquity
$80.26 /

+1.09 (+1.38%)

CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

ASLE AerSale
$11.15 /

+1.155 (+11.56%)

AMPH Amphastar
$19.17 /

-0.21 (-1.08%)

ACRX AcelRx
$2.17 /

-0.04 (-1.81%)

  • 18
    Mar
  • 16
    Mar
  • 18
    Mar
  • 17
    Feb
  • 20
    Jan
  • 07
    Oct
  • 09
    Jul
  • 14
    Apr
NWS News Corp
$24.73 /

-0.19 (-0.76%)

NKLA Nikola
$17.07 /

+0.07 (+0.41%)

IMAX Imax
$23.45 /

-0.02 (-0.09%)

CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

NWS News Corp
$24.73 /

-0.19 (-0.76%)

NKLA Nikola
$17.07 /

+0.07 (+0.41%)

MAXR Maxar Technologies
$47.79 /

+1.07 (+2.29%)

INSP Inspire Medical
$217.98 /

-0.26 (-0.12%)

IMAX Imax
$23.45 /

-0.02 (-0.09%)

HQY HealthEquity
$80.26 /

+1.09 (+1.38%)

CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

AMPH Amphastar
$19.17 /

-0.21 (-1.08%)

ZDGE Zedge
$11.48 /

+1.2 (+11.67%)

PAYA Paya Holdings
$13.28 /

+0.03 (+0.23%)

NWS News Corp
$24.73 /

-0.19 (-0.76%)

NKLA Nikola
$17.07 /

+0.07 (+0.41%)

MAXR Maxar Technologies
$47.79 /

+1.07 (+2.29%)

IMAX Imax
$23.45 /

-0.02 (-0.09%)

CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

ACRX AcelRx
$2.17 /

-0.04 (-1.81%)

Hot Stocks
Inspire Medical gets FDA approval of two-incision implant procedure » 16:14
03/15/21
03/15
16:14
03/15/21
16:14
INSP

Inspire Medical

$217.93 /

-0.31 (-0.14%)

Inspire Medical Systems…

Inspire Medical Systems announced receipt of U.S. Food and Drug Administration approval for an improved surgical implant procedure that eliminates one incision with a revised placement of the pressure sensing lead. This newly approved procedure will reduce the average procedure time for Inspire therapy by approximately 20% ."Delivering consistent positive patient outcomes remains Inspire's number one priority, and the receipt of FDA approval for this two-incision procedure represents further evidence of our commitment to the continuous improvement of Inspire therapy," said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems. "The new procedure places the sensor in the intercostal muscles directly behind the neurostimulator pocket, thereby eliminating the need for a third incision lower on the chest and the additional requirement to tunnel the sensing lead under the skin to the neurostimulator. A number of ENT surgeons highly experienced with the current Inspire implant procedure initiated the development of this new surgical technique. With this approval, we now intend to leverage our broad network of leading ENT's to further improve the Inspire procedure and enhance therapy outcomes."

ShowHide Related Items >><<
INSP Inspire Medical
$217.93 /

-0.31 (-0.14%)

INSP Inspire Medical
$217.93 /

-0.31 (-0.14%)

02/24/21 Lake Street
Inspire Medical price target raised to $250 from $215 at Lake Street
02/24/21 SVB Leerink
Inspire Medical price target raised to $275 from $225 at SVB Leerink
02/24/21 Piper Sandler
Inspire Medical price target raised to $252 from $210 at Piper Sandler
01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
INSP Inspire Medical
$217.93 /

-0.31 (-0.14%)

  • 14
    Apr
INSP Inspire Medical
$217.93 /

-0.31 (-0.14%)

Conference/Events
Inspire Medical participates in a conference call with JPMorgan » 09:53
03/05/21
03/05
09:53
03/05/21
09:53
INSP

Inspire Medical

$211.00 /

-4.73 (-2.19%)

Medical Supplies &…

Medical Supplies & Devices Analyst Marcus holds a conference call with CEO Herbert on March 5 at 11 am hosted by JPMorgan.

ShowHide Related Items >><<
INSP Inspire Medical
$211.00 /

-4.73 (-2.19%)

INSP Inspire Medical
$211.00 /

-4.73 (-2.19%)

02/24/21 Lake Street
Inspire Medical price target raised to $250 from $215 at Lake Street
02/24/21 SVB Leerink
Inspire Medical price target raised to $275 from $225 at SVB Leerink
02/24/21 Piper Sandler
Inspire Medical price target raised to $252 from $210 at Piper Sandler
01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
INSP Inspire Medical
$211.00 /

-4.73 (-2.19%)

  • 14
    Apr
INSP Inspire Medical
$211.00 /

-4.73 (-2.19%)

Recommendations
Inspire Medical price target raised to $250 from $215 at Lake Street » 09:02
02/24/21
02/24
09:02
02/24/21
09:02
INSP

Inspire Medical

$220.00 /

-3.32 (-1.49%)

Lake Street analyst Frank…

Lake Street analyst Frank Takkinen raised the firm's price target on Inspire Medical to $250 from $215 and keeps a Buy rating on the shares after the company reported accelerating revenue growth in Q4 and gave what he calls "impressive" guidance. He sees the company "building a durable competitive moat to further protect their impressive lead to competition," Takkinen tells investors in a post-earnings research note.

ShowHide Related Items >><<
INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

02/24/21 SVB Leerink
Inspire Medical price target raised to $275 from $225 at SVB Leerink
02/24/21 Piper Sandler
Inspire Medical price target raised to $252 from $210 at Piper Sandler
01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
01/04/21 BofA
Inspire Medical downgraded to Neutral from Buy at BofA
INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

  • 14
    Apr
INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

Recommendations
Inspire Medical price target raised to $275 from $225 at SVB Leerink » 07:54
02/24/21
02/24
07:54
02/24/21
07:54
INSP

Inspire Medical

$220.00 /

-3.32 (-1.49%)

SVB Leerink analyst…

SVB Leerink analyst Richard Newitter raised the firm's price target on Inspire Medical to $275 from $225 and keeps an Outperform rating on the shares following the company's Q4 revenue beat and above consensus 2021 revenue outlook. The analyst continues to believe Inspire Medical is at a reimbursement "tipping point" that should lead to accelerated adoption and continued upward bias to consensus out-year forecasts as the company is in a strong position to penetrate a large/still underpenetrated TAM.

ShowHide Related Items >><<
INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

02/24/21 Piper Sandler
Inspire Medical price target raised to $252 from $210 at Piper Sandler
01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
01/04/21 BofA
Inspire Medical downgraded to Neutral from Buy at BofA
12/15/20 Goldman Sachs
Inspire Medical downgraded to Neutral from Buy at Goldman Sachs
INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

  • 14
    Apr
INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

Recommendations
Inspire Medical price target raised to $252 from $210 at Piper Sandler » 04:50
02/24/21
02/24
04:50
02/24/21
04:50
INSP

Inspire Medical

$220.00 /

-3.32 (-1.49%)

Piper Sandler analyst…

Piper Sandler analyst Adam Maeder raised the firm's price target on Inspire Medical to $252 from $210 and reiterates an Overweight rating on the shares following the company's Q4 results. While the quarter was aided to a modest degree by catch-up procedures, the underlying strength was "evident and impressive," Maeder tells investors in a research note. Inspire is bringing "substantial commercial" momentum into 2021 despite COVID-19, says the analyst.

ShowHide Related Items >><<
INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
01/04/21 BofA
Inspire Medical downgraded to Neutral from Buy at BofA
12/15/20 Goldman Sachs
Inspire Medical downgraded to Neutral from Buy at Goldman Sachs
12/03/20 Piper Sandler
Inspire Medical price target raised to $210 from $147 at Piper Sandler
INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

  • 14
    Apr
INSP Inspire Medical
$220.00 /

-3.32 (-1.49%)

Hot Stocks
Inspire appoints Bryan Phillips as chief compliance officer, general counsel » 16:08
01/19/21
01/19
16:08
01/19/21
16:08
INSP

Inspire Medical

$224.07 /

+14.13 (+6.73%)

, CERE

Cerevel Therapeutics

$14.51 /

+0.095 (+0.66%)

Inspire Medical (INSP)…

Inspire Medical (INSP) announced the appointment of Bryan Phillips as senior VP, general counsel, chief compliance officer and corporate secretary. Phillips is a legal executive with broad corporate experience in the healthcare industry.Most recently, Phillips served as chief legal officer at Cerevel Therapeutics (CERE).

ShowHide Related Items >><<
INSP Inspire Medical
$224.07 /

+14.13 (+6.73%)

CERE Cerevel Therapeutics
$14.51 /

+0.095 (+0.66%)

INSP Inspire Medical
$224.07 /

+14.13 (+6.73%)

01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
01/04/21 BofA
Inspire Medical downgraded to Neutral from Buy at BofA
12/15/20 Goldman Sachs
Inspire Medical downgraded to Neutral from Buy at Goldman Sachs
12/03/20 Piper Sandler
Inspire Medical price target raised to $210 from $147 at Piper Sandler
CERE Cerevel Therapeutics
$14.51 /

+0.095 (+0.66%)

12/10/20 Goldman Sachs
Cerevel Therapeutics initiated with a Buy at Goldman Sachs
11/23/20 Jefferies
Cerevel Therapeutics initiated with a Buy at Jefferies
11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Stifel
Cerevel Therapeutics initiated with a Buy at Stifel
INSP Inspire Medical
$224.07 /

+14.13 (+6.73%)

  • 14
    Apr
INSP Inspire Medical
$224.07 /

+14.13 (+6.73%)

CERE Cerevel Therapeutics
$14.51 /

+0.095 (+0.66%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.